Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

Infect Dis Clin North Am. 2010 Jun;24(2):319-37. doi: 10.1016/j.idc.2010.01.008.

Abstract

This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV are examined.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Cytomegalovirus / pathogenicity
  • Cytomegalovirus Infections / drug therapy*
  • Cytomegalovirus Infections / transmission*
  • Disease Transmission, Infectious*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immunocompromised Host*
  • Immunotherapy, Adoptive / methods
  • Virus Latency

Substances

  • Antiviral Agents